Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting

Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting

Blog Article

A cross-sectional study was conducted to predict time in therapeutic range (TTR) using clinical history, examination, and socioeconomic data.Study included warfarin-receiving patients from outpatient-clinic.In 203 patients studied, mean warfarin start-dose was 2.

55 mg/day and maintenance-dose/week was 30.79 mg.Body mass Womens Hoodies index (BMI) (p = 0.

03), warfarin maintenance dose/day (p = 0.02), and comorbidity presence (p = 0.04) were significantly associated with TTR.

Occupation (p = 0.53), income (p = 0.83), education (p = 0.

55), and socioeconomic score (p = 0.73) showed non-significant association with TTR.A TTR TAMP-SUPER PLUS predicting nomogram was built from clinical history and examination findings.